Real-world cohort study evaluates GLP-1 receptor agonists' impact on neurological outcomes in brain tumor patients, suggesting potential benefits.
To evaluate whether GLP-1 receptor agonist (GLP-1RA) therapy is associated with improved neurological outcomes, including mortality, seizure incidence, and ICU admissions in adults with primary brain tumors.
No takes yet. Share an insight, caveat, or question.
Sachdeva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: